All News

Oct 19, 2026 TRIANA Biomedicines Announces Participation in Goldman Sachs’ Healthcare Private Company Conference Read More Sep 9, 2026 TRIANA Biomedicines Announces Publication of Preclinical Data Supporting Clinical Advancement of TRI-611 Read More Sep 2, 2026 TRIANA Biomedicines Announces Participation in Upcoming Investor Conferences Read More May 18, 2026 TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board Read More Apr 15, 2026 TRIANA Biomedicines Announces Oral Presentation of TRI-611 and Additional Poster Presentations at the American Association for Cancer Research Annual Meeting 2026 Read More Mar 25, 2026 TRIANA Biomedicines’ TRI-611 Granted U.S. FDA Fast Track Designation for Treatment of ALK Positive Non-small Cell Lung Cancer Read More Mar 19, 2026 TRIANA Biomedicines Announces First Patient Dosed in a Phase 1/2 Trial Evaluating TRI-611 for the Treatment of ALK Positive Non-small Cell Lung Cancer Read More Jan 6, 2026 TRIANA Biomedicines Enters into a Research Collaboration with Johnson & Johnson to Identify Oncology Molecular Glue Degraders Read More Dec 12, 2025 Pfizer and TRIANA Biomedicines Named Recipients of Scrip’s 2025 Best Partnership Alliance Award for Their Collaboration on Molecular Glue Degraders Read More Dec 3, 2025 TRIANA Biomedicines Announces the Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline Read More May 7, 2025 TRIANA Biomedicines Announces the Appointment of Caroline Germa as Chief Medical Officer and Attracts Leading Drug Discovery and Development Expert to its Scientific Advisory Board Read More Oct 15, 2024 TRIANA Biomedicines and Pfizer Enter Into A Research Collaboration to Discover Novel Molecular Glue Degraders for Multiple Disease Areas Read More Sep 18, 2023 TRIANA Biomedicines to Present at UBS Biotechnology Private Company Virtual Symposium Read More Sep 12, 2023 TRIANA Biomedicines Announces the Appointments of Vito Palombella as Chief Scientific Officer and Reza Mazhari as Chief Business Officer Read More Jan 5, 2023 TRIANA Biomedicines Named Most Promising New Company in BioSpace’s NextGen 2023 List Read More Sep 19, 2022 TRIANA Biomedicines Announces Participation in Upcoming Investor Conference Read More Jun 23, 2022 TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board Read More Apr 6, 2022 TRIANA Biomedicines Launches With $110M to Unlock the Full Potential of Molecular Glues Read More